Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bicycle Therapeutics (BCYC – Research Report), Turning Point Therapeutics (TPTX – Research Report) and Globus Medical (GMED – Research Report).
Bicycle Therapeutics (BCYC)
In a report released today, Reni Benjamin from JMP Securities reiterated a Buy rating on Bicycle Therapeutics, with a price target of $70.00. The company’s shares closed last Friday at $15.23, close to its 52-week low of $14.43.
According to TipRanks.com, Benjamin has 0 stars on 0-5 stars ranking scale with an average return of
Bicycle Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $60.00, representing a 285.4% upside. In a report issued on May 23, Piper Sandler also maintained a Buy rating on the stock with a $37.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Turning Point Therapeutics (TPTX)
In a report released today, Silvan Tuerkcan from JMP Securities maintained a Hold rating on Turning Point Therapeutics. The company’s shares closed last Friday at $74.59, close to its 52-week high of $83.06.
According to TipRanks.com, Tuerkcan is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Turning Point Therapeutics is a Moderate Buy with an average price target of $81.80, a 10.9% upside from current levels. In a report issued on June 3, Wedbush also downgraded the stock to Hold with a $76.00 price target.
Globus Medical (GMED)
In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Globus Medical. The company’s shares closed last Friday at $63.53.
According to TipRanks.com, Turkaly is a 3-star analyst with an average return of
Currently, the analyst consensus on Globus Medical is a Moderate Buy with an average price target of $73.17.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BCYC:
